Submitted by Anonymous (not verified) on 4 March 2026 - 13:23
Opinion/decision on a Paediatric investigation plan (PIP): Zeftera (previously Zevtera), ceftobiprole medocaril (sodium), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: EMA/PE/0000227526
Source: